6.74
price down icon0.74%   -0.05
after-market Dopo l'orario di chiusura: 6.67 -0.07 -1.04%
loading
Precedente Chiudi:
$6.79
Aprire:
$7.03
Volume 24 ore:
1.97M
Relative Volume:
0.68
Capitalizzazione di mercato:
$307.86M
Reddito:
$27.10M
Utile/perdita netta:
$-24.31M
Rapporto P/E:
-8.1205
EPS:
-0.83
Flusso di cassa netto:
$-33.33M
1 W Prestazione:
+3.37%
1M Prestazione:
-39.55%
6M Prestazione:
-52.77%
1 anno Prestazione:
+58.59%
Intervallo 1D:
Value
$6.61
$7.10
Intervallo di 1 settimana:
Value
$6.26
$7.28
Portata 52W:
Value
$3.52
$23.40

Capricor Therapeutics Inc Stock (CAPR) Company Profile

Name
Nome
Capricor Therapeutics Inc
Name
Telefono
(310) 358-3200
Name
Indirizzo
8840 WILSHIRE BLVD, BEVERLY HILLS, CA
Name
Dipendente
160
Name
Cinguettio
@Capricor
Name
Prossima data di guadagno
2025-03-19
Name
Ultimi documenti SEC
Name
CAPR's Discussions on Twitter

Confronta CAPR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CAPR
Capricor Therapeutics Inc
6.74 310.36M 27.10M -24.31M -33.33M -0.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
468.41 118.34B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.14 60.31B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
330.55 42.35B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
598.79 36.43B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
305.74 31.87B 3.81B -644.79M -669.77M -6.24

Capricor Therapeutics Inc Stock (CAPR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-30 Iniziato Alliance Global Partners Buy
2025-06-26 Iniziato B. Riley Securities Buy
2025-05-20 Iniziato Roth Capital Buy
2024-10-21 Iniziato Piper Sandler Overweight
2024-05-17 Iniziato Oppenheimer Outperform
2024-01-05 Iniziato Cantor Fitzgerald Overweight
2022-10-26 Iniziato Ladenburg Thalmann Buy
2018-12-26 Downgrade Maxim Group Buy → Hold
2018-01-26 Reiterato H.C. Wainwright Buy
2017-09-15 Reiterato H.C. Wainwright Buy
2017-02-13 Ripresa Rodman & Renshaw Buy
2016-07-06 Ripresa H.C. Wainwright Buy
2016-06-15 Iniziato ROTH Capital Buy
Mostra tutto

Capricor Therapeutics Inc Borsa (CAPR) Ultime notizie

pulisher
Jul 29, 2025

Shareholders that lost money on Capricor Therapeutics should contact Faruqi & Faruqi about pending Class ActionCAPR - The Malaysian Reserve

Jul 29, 2025
pulisher
Jul 29, 2025

Capricor Investors Sue Over Misleading FDA Approval Claims – What You Need to Know - TradingView

Jul 29, 2025
pulisher
Jul 29, 2025

Capricor Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 15, 2025 to Discuss Your RightsCAPR - PR Newswire

Jul 29, 2025
pulisher
Jul 29, 2025

Shareholders of Capricor Therapeutics, Inc. (CAPR): Protect Your Rights Before September 15, 2025Contact Levi & Korsinsky - TradingView

Jul 29, 2025
pulisher
Jul 29, 2025

What makes Capricor Therapeutics Inc. stock price move sharplyAI Triggered Buy Zone Forecast System - Newser

Jul 29, 2025
pulisher
Jul 29, 2025

How to manage a losing position in Capricor Therapeutics Inc.Daily Profit Watch With Forecast Confidence - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

Class Action Filed Against Capricor Therapeutics, Inc. - GlobeNewswire

Jul 28, 2025
pulisher
Jul 28, 2025

Bragar Eagel & Squire, P.C. Urges Investors in XPLR - GlobeNewswire

Jul 28, 2025
pulisher
Jul 28, 2025

Bragar Eagel & Squire, P.C. Urges Investors in XPLR Infrastructure, Centene, Biohaven, or Capricor to Inquire About Their Rights in Class Action Lawsuits - GlobeNewswire Inc.

Jul 28, 2025
pulisher
Jul 28, 2025

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire

Jul 28, 2025
pulisher
Jul 28, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor ... - Bluefield Daily Telegraph

Jul 28, 2025
pulisher
Jul 28, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc.CAPR - FinancialContent

Jul 28, 2025
pulisher
Jul 28, 2025

Capricor Therapeutics to Host Webinar on Deramiocel and Duchenne Muscular Dystrophy in Collaboration with Parent Project Muscular Dystrophy - Quiver Quantitative

Jul 28, 2025
pulisher
Jul 28, 2025

Capricor Therapeutics and Parent Project Muscular Dystrophy - GlobeNewswire

Jul 28, 2025
pulisher
Jul 28, 2025

Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar to Review Latest Developments in the Deramiocel Program for the Treatment of Duchenne Muscular Dystrophy - Yahoo Finance

Jul 28, 2025
pulisher
Jul 28, 2025

Class Action Filed Against Capricor Therapeutics, Inc. (CAPR) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire

Jul 28, 2025
pulisher
Jul 28, 2025

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire

Jul 28, 2025
pulisher
Jul 28, 2025

Relative strength of Capricor Therapeutics Inc. in sector analysisAI Entry Timing Prediction for Swing Traders - Newser

Jul 28, 2025
pulisher
Jul 27, 2025

What is the risk reward ratio of investing in Capricor Therapeutics Inc. stockTrack emerging stocks with high growth potential - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Lost Money on Capricor Therapeutics, Inc. (CAPR)? Contact Levi & Korsinsky Before September 15, 2025 to Join Class Action - ACCESS Newswire

Jul 27, 2025
pulisher
Jul 27, 2025

CAPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - ACCESS Newswire

Jul 27, 2025
pulisher
Jul 27, 2025

What are analysts’ price targets for Capricor Therapeutics Inc. in the next 12 monthsBuild your wealth with consistent stock growth - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

Investors who lost money on Capricor Therapeutics, Inc. - GlobeNewswire

Jul 25, 2025
pulisher
Jul 25, 2025

CAPR Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the ... - Bluefield Daily Telegraph

Jul 25, 2025
pulisher
Jul 25, 2025

CAPR Class Action Alert: Robbins LLP Reminds Investors of - GlobeNewswire

Jul 25, 2025
pulisher
Jul 25, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire

Jul 25, 2025
pulisher
Jul 25, 2025

Join Class Action to Recover Losses from Capricor Therapeutics, Inc. (CAPR)Contact Levi & Korsinsky Before September 15, 2025 - Newsfile

Jul 25, 2025
pulisher
Jul 25, 2025

Levi & Korsinsky Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025CAPR - PR Newswire

Jul 25, 2025
pulisher
Jul 25, 2025

Should I buy Capricor Therapeutics Inc. stock before earningsHigh-yield capital appreciation - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Capricor Therapeutics Inc. stockUnstoppable trading performance - Autocar Professional

Jul 25, 2025
pulisher
Jul 24, 2025

Is Capricor Therapeutics Inc. a good long term investmentSignificant capital appreciation - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Investors who lost money on Capricor Therapeutics, - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

Capricor Therapeutics Inc. Stock Analysis and ForecastExtraordinary earning power - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Arizona State Retirement System Buys Shares of 11,707 Capricor Therapeutics, Inc. (NASDAQ:CAPR) - Defense World

Jul 24, 2025
pulisher
Jul 24, 2025

Shareholders that lost money on Capricor Therapeutics, Inc.(CAPR) Urged to Join Class ActionContact The Gross Law Firm to Learn More - Barchart.com

Jul 24, 2025
pulisher
Jul 24, 2025

Recover Investment Losses: Levi & Korsinsky Files Class Action Against Capricor Therapeutics, Inc. (CAPR) - TradingView

Jul 24, 2025
pulisher
Jul 23, 2025

CAPRICOR THERAPEUTICS, INC. (NASDAQ:CAPR) DEADLINE ALERT Bernstein Liebhard LLP Reminds Capricor Therapeutics, Inc. Investors of Upcoming Deadline - ACCESS Newswire

Jul 23, 2025
pulisher
Jul 23, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics - ETX View

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Capricor Therapeutics Inc. stock priceOutperformance with explosive growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Capricor Therapeutics, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsCAPR - Business Wire

Jul 22, 2025
pulisher
Jul 22, 2025

Levi & Korsinsky Announces the Filing of a Securities Class - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

ROSEN, LEADING INVESTOR COUNSEL, Encourages Capricor - GlobeNewswire

Jul 22, 2025
pulisher
Jul 22, 2025

Capricor Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Capricor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025CAPR - PR Newswire

Jul 22, 2025
pulisher
Jul 22, 2025

Behind Capricor Therapeutics Inc’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com

Jul 22, 2025
pulisher
Jul 22, 2025

Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) 15% loss last week hit both individual investors who own 47% as well as institutions - simplywall.st

Jul 22, 2025
pulisher
Jul 22, 2025

Capricor Therapeutics, Inc. Securities Fraud Class Action - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

CAPRICOR THERAPEUTICS, INC. (NASDAQ: CAPR) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Capricor Therapeutics, Inc. Investors of Upcoming Deadline - ACCESS Newswire

Jul 21, 2025
pulisher
Jul 21, 2025

(CAPR) Technical Data - news.stocktradersdaily.com

Jul 21, 2025
pulisher
Jul 21, 2025

Securities Fraud and Market Volatility in Biotech: Lessons from Capricor's Downfall - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Rosen Law Firm Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire

Jul 21, 2025
pulisher
Jul 21, 2025

Investors Urged to Contact Levi & Korsinsky for Information Before September 15, 2025Capricor Therapeutics, Inc. (CAPR) - TradingView

Jul 21, 2025

Capricor Therapeutics Inc Azioni (CAPR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$77.38
price up icon 10.28%
$37.27
price up icon 0.57%
$105.00
price up icon 3.19%
$26.74
price down icon 2.59%
$111.48
price down icon 1.16%
biotechnology ONC
$305.74
price up icon 3.81%
Capitalizzazione:     |  Volume (24 ore):